Multimodality treatment. A two-year evaluation of 61 hyperactive boys.
This study reports findings at the end of the second year of a three-year prospective study of 61 hyperactive boys. Individualized multimodality treatment plans commensurate with each child's disabilities were implemented by the research staff. Measures of the child's behavior at home and at school, academic performance, delinquent behavior, and emotional adjustment were obtained initially and at the end of each treatment year. The combination of a clinically useful medication in appropriate dosage schedules with relevant psychological treatments simultaneously directed to each of the child's many disabilities were associated with an unexpectedly good outcome at the end of one and two years. Whether this improvement will be maintained over a longer period of time and whether young adult outcome will be affected await further investigation.
D000124:Achievement; D001288:Attention / Q000187:drug effects; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D009043:Motor Activity / Q000187:drug effects; D010389:Pemoline / Q000627:therapeutic use; D011613:Psychotherapy; D012917:Social Adjustment; D013881:Thioridazine / Q000627:therapeutic use
D008774:Methylphenidate; D010389:Pemoline; D013881:Thioridazine; D003913:Dextroamphetamine